chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Agitation, Chills, Fatigue, Heart rate increased, Hyperhidrosis
Clinical narrative: Muscle pain; Fatigue; Chills; Nausea; Injection site redness; Injection site swelling; vomiting; Agitated; broke out in to a sweat and went to the bathroom; Heart was racing; Injection site pain; This spontaneous case was reported by a nurse and describes the occurrence of AGITATION (Agitated), HYPERHIDROSIS (broke out in to a sweat and went to the bathroom), HEART RATE INCREASED (Heart was racing), MYALGIA (Muscle pain) and FATIGUE (Fatigue) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Cirrhosis liver. Concurrent medical conditions included Obesity, Diabetes, Drug allergy (NSAIDs), Drug allergy (Patient is allergic to Tequin.), Drug allergy (Patient is allergic to Levaquin.), Drug allergy (Patient is allergic to Cardizem.) and Drug allergy (Patient is allergic to Lyrica.).    On 09-Mar-2021 at 11:20 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, the patient experienced AGITATION (Agitated), HYPERHIDROSIS (broke out in to a sweat and went to the bathroom), HEART RATE INCREASED (Heart was racing) and INJECTION SITE PAIN (Injection site pain). On 11-Mar-2021, the patient experienced MYALGIA (Muscle pain), FATIGUE (Fatigue), CHILLS (Chills), NAUSEA (Nausea), INJECTION SITE ERYTHEMA (Injection site redness), INJECTION SITE SWELLING (Injection site swelling) and VOMITING (vomiting). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at a dose of unknown. At the time of the report, AGITATION (Agitated), HYPERHIDROSIS (broke out in to a sweat and went to the bathroom), HEART RATE INCREASED (Heart was racing), MYALGIA (Muscle pain), FATIGUE (Fatigue), CHILLS (Chills), NAUSEA (Nausea), INJECTION SITE PAIN (Injection site pain), INJECTION SITE ERYTHEMA (Injection site redness), INJECTION SITE SWELLING (Injection site swelling) and VOMITING (vomiting) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Mar-2021, Vital signs measurement: normal (normal) normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported.   Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: patient medical history has been updated.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Myalgia, Nausea
Clinical narrative: Muscle pain; Fatigue; Chills; Nausea; Injection site redness; Injection site swelling; vomiting; Agitated; broke out in to a sweat and went to the bathroom; Heart was racing; Injection site pain; This spontaneous case was reported by a nurse and describes the occurrence of AGITATION (Agitated), HYPERHIDROSIS (broke out in to a sweat and went to the bathroom), HEART RATE INCREASED (Heart was racing), MYALGIA (Muscle pain) and FATIGUE (Fatigue) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Cirrhosis liver. Concurrent medical conditions included Obesity, Diabetes, Drug allergy (NSAIDs), Drug allergy (Patient is allergic to Tequin.), Drug allergy (Patient is allergic to Levaquin.), Drug allergy (Patient is allergic to Cardizem.) and Drug allergy (Patient is allergic to Lyrica.).    On 09-Mar-2021 at 11:20 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, the patient experienced AGITATION (Agitated), HYPERHIDROSIS (broke out in to a sweat and went to the bathroom), HEART RATE INCREASED (Heart was racing) and INJECTION SITE PAIN (Injection site pain). On 11-Mar-2021, the patient experienced MYALGIA (Muscle pain), FATIGUE (Fatigue), CHILLS (Chills), NAUSEA (Nausea), INJECTION SITE ERYTHEMA (Injection site redness), INJECTION SITE SWELLING (Injection site swelling) and VOMITING (vomiting). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at a dose of unknown. At the time of the report, AGITATION (Agitated), HYPERHIDROSIS (broke out in to a sweat and went to the bathroom), HEART RATE INCREASED (Heart was racing), MYALGIA (Muscle pain), FATIGUE (Fatigue), CHILLS (Chills), NAUSEA (Nausea), INJECTION SITE PAIN (Injection site pain), INJECTION SITE ERYTHEMA (Injection site redness), INJECTION SITE SWELLING (Injection site swelling) and VOMITING (vomiting) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Mar-2021, Vital signs measurement: normal (normal) normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported.   Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: patient medical history has been updated.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Vital signs measurement, Vomiting
Clinical narrative: Muscle pain; Fatigue; Chills; Nausea; Injection site redness; Injection site swelling; vomiting; Agitated; broke out in to a sweat and went to the bathroom; Heart was racing; Injection site pain; This spontaneous case was reported by a nurse and describes the occurrence of AGITATION (Agitated), HYPERHIDROSIS (broke out in to a sweat and went to the bathroom), HEART RATE INCREASED (Heart was racing), MYALGIA (Muscle pain) and FATIGUE (Fatigue) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Cirrhosis liver. Concurrent medical conditions included Obesity, Diabetes, Drug allergy (NSAIDs), Drug allergy (Patient is allergic to Tequin.), Drug allergy (Patient is allergic to Levaquin.), Drug allergy (Patient is allergic to Cardizem.) and Drug allergy (Patient is allergic to Lyrica.).    On 09-Mar-2021 at 11:20 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, the patient experienced AGITATION (Agitated), HYPERHIDROSIS (broke out in to a sweat and went to the bathroom), HEART RATE INCREASED (Heart was racing) and INJECTION SITE PAIN (Injection site pain). On 11-Mar-2021, the patient experienced MYALGIA (Muscle pain), FATIGUE (Fatigue), CHILLS (Chills), NAUSEA (Nausea), INJECTION SITE ERYTHEMA (Injection site redness), INJECTION SITE SWELLING (Injection site swelling) and VOMITING (vomiting). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at a dose of unknown. At the time of the report, AGITATION (Agitated), HYPERHIDROSIS (broke out in to a sweat and went to the bathroom), HEART RATE INCREASED (Heart was racing), MYALGIA (Muscle pain), FATIGUE (Fatigue), CHILLS (Chills), NAUSEA (Nausea), INJECTION SITE PAIN (Injection site pain), INJECTION SITE ERYTHEMA (Injection site redness), INJECTION SITE SWELLING (Injection site swelling) and VOMITING (vomiting) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Mar-2021, Vital signs measurement: normal (normal) normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported.   Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: patient medical history has been updated.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Lip swelling, Pruritus, Urticaria
Clinical narrative: Lip swelling; Chest tightness; Itching; Urticaria; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of URTICARIA (Urticaria), LIP SWELLING (Lip swelling), CHEST DISCOMFORT (Chest tightness) and PRURITUS (Itching) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011J20A and 011J20A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On 09-Mar-2021, the patient experienced URTICARIA (Urticaria) and PRURITUS (Itching). On 11-Mar-2021, the patient experienced LIP SWELLING (Lip swelling) and CHEST DISCOMFORT (Chest tightness). The patient was treated with PREDNISONE at a dose of 40 mg once a day; FAMOTIDINE at a dose of 40 mg once a day and DIPHENHYDRAMINE at a dose of 25 mg. At the time of the report, URTICARIA (Urticaria), LIP SWELLING (Lip swelling), CHEST DISCOMFORT (Chest tightness) and PRURITUS (Itching) had not resolved.            Action taken with mRNA-1273 in response to the event was not applicable
Sex: F
Vaccine: COVID19, UNK
Symptoms: Headache, Myalgia
Clinical narrative: Body aches; Headache; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Body aches) and HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product LENVATINIB MESILATE (LENVIMA) for Endometrial cancer.    Previously administered products included for Product used for unknown indication: Keytruda (Keytruda infusions). Past adverse reactions to the above products included No adverse reaction with Keytruda. Concurrent medical conditions included Endometrial cancer.   On 10-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Mar-2021, the patient started LENVATINIB MESILATE (LENVIMA) (unknown route) 10 milligram once a day. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, the patient experienced MYALGIA (Body aches) and HEADACHE (Headache). At the time of the report, MYALGIA (Body aches) and HEADACHE (Headache) outcome was unknown.            No treatment information was provided.  Action taken with mRNA-1273 in response to the event was not applicable..
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Balance disorder, Fall, Hyperhidrosis, Muscle spasms, Pain
Clinical narrative: Fall; Sweat; Muscle cramps worse; Soreness; Poor balance worsened; Blurry vision worse; Fever; This spontaneous case was reported by a consumer and describes the occurrence of FALL (Fall), HYPERHIDROSIS (Sweat), MUSCLE SPASMS (Muscle cramps worse), PAIN (Soreness) and BALANCE DISORDER (Poor balance worsened) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Multiple sclerosis. Concomitant products included OCRELIZUMAB (OCREVUS) for an unknown indication.    On 09-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2021, the patient experienced FALL (Fall), HYPERHIDROSIS (Sweat), MUSCLE SPASMS (Muscle cramps worse), PAIN (Soreness), BALANCE DISORDER (Poor balance worsened), VISION BLURRED (Blurry vision worse) and PYREXIA (Fever). At the time of the report, FALL (Fall), HYPERHIDROSIS (Sweat), MUSCLE SPASMS (Muscle cramps worse), PAIN (Soreness), BALANCE DISORDER (Poor balance worsened), VISION BLURRED (Blurry vision worse) and PYREXIA (Fever) had not resolved.            The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable.  Treatment information was not provided.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Vision blurred
Clinical narrative: Fall; Sweat; Muscle cramps worse; Soreness; Poor balance worsened; Blurry vision worse; Fever; This spontaneous case was reported by a consumer and describes the occurrence of FALL (Fall), HYPERHIDROSIS (Sweat), MUSCLE SPASMS (Muscle cramps worse), PAIN (Soreness) and BALANCE DISORDER (Poor balance worsened) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Multiple sclerosis. Concomitant products included OCRELIZUMAB (OCREVUS) for an unknown indication.    On 09-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2021, the patient experienced FALL (Fall), HYPERHIDROSIS (Sweat), MUSCLE SPASMS (Muscle cramps worse), PAIN (Soreness), BALANCE DISORDER (Poor balance worsened), VISION BLURRED (Blurry vision worse) and PYREXIA (Fever). At the time of the report, FALL (Fall), HYPERHIDROSIS (Sweat), MUSCLE SPASMS (Muscle cramps worse), PAIN (Soreness), BALANCE DISORDER (Poor balance worsened), VISION BLURRED (Blurry vision worse) and PYREXIA (Fever) had not resolved.            The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable.  Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site mass, Vaccination site pruritus
Clinical narrative: Itchy pink lump arm; Itchy pink lump on arm; Itchy pink lump arm; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Itchy pink lump arm), VACCINATION SITE PRURITUS (Itchy pink lump on arm) and VACCINATION SITE ERYTHEMA (Itchy pink lump arm) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced VACCINATION SITE MASS (Itchy pink lump arm), VACCINATION SITE PRURITUS (Itchy pink lump on arm) and VACCINATION SITE ERYTHEMA (Itchy pink lump arm). At the time of the report, VACCINATION SITE MASS (Itchy pink lump arm), VACCINATION SITE PRURITUS (Itchy pink lump on arm) and VACCINATION SITE ERYTHEMA (Itchy pink lump arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient reported that it was a bit of delayed reaction.  No concomitant medications were reported.  No treatment information was provided.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Headache, Nausea
Clinical narrative: Dizziness; headache; tired; woke up nauseous; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (tired), NAUSEA (woke up nauseous), HEADACHE (headache) and DIZZINESS (Dizziness) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced FATIGUE (tired) and NAUSEA (woke up nauseous). On 05-Mar-2021, the patient experienced HEADACHE (headache). On 08-Mar-2021, the patient experienced DIZZINESS (Dizziness). At the time of the report, FATIGUE (tired), NAUSEA (woke up nauseous), HEADACHE (headache) and DIZZINESS (Dizziness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling jittery, Muscular weakness, Nausea, Pain in extremity
Clinical narrative: Heart pounding really bad; Vertigo feeling; Legs feel jello like; Jittery feeling; Sore arm; Tired; Feeling queasy; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (Heart pounding really bad), VERTIGO (Vertigo feeling), MUSCULAR WEAKNESS (Legs feel jello like), FEELING JITTERY (Jittery feeling) and PAIN IN EXTREMITY (Sore arm) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PALPITATIONS (Heart pounding really bad), VERTIGO (Vertigo feeling), MUSCULAR WEAKNESS (Legs feel jello like), FEELING JITTERY (Jittery feeling), PAIN IN EXTREMITY (Sore arm), FATIGUE (Tired) and NAUSEA (Feeling queasy). At the time of the report, PALPITATIONS (Heart pounding really bad), VERTIGO (Vertigo feeling), MUSCULAR WEAKNESS (Legs feel jello like), FEELING JITTERY (Jittery feeling), PAIN IN EXTREMITY (Sore arm), FATIGUE (Tired) and NAUSEA (Feeling queasy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product used was not provided by the reporter.  Treatment information was not provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: Follow-up information will be processed at the same time as the initial report. Follow-up updated outcome for events.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Palpitations, Vertigo
Clinical narrative: Heart pounding really bad; Vertigo feeling; Legs feel jello like; Jittery feeling; Sore arm; Tired; Feeling queasy; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (Heart pounding really bad), VERTIGO (Vertigo feeling), MUSCULAR WEAKNESS (Legs feel jello like), FEELING JITTERY (Jittery feeling) and PAIN IN EXTREMITY (Sore arm) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PALPITATIONS (Heart pounding really bad), VERTIGO (Vertigo feeling), MUSCULAR WEAKNESS (Legs feel jello like), FEELING JITTERY (Jittery feeling), PAIN IN EXTREMITY (Sore arm), FATIGUE (Tired) and NAUSEA (Feeling queasy). At the time of the report, PALPITATIONS (Heart pounding really bad), VERTIGO (Vertigo feeling), MUSCULAR WEAKNESS (Legs feel jello like), FEELING JITTERY (Jittery feeling), PAIN IN EXTREMITY (Sore arm), FATIGUE (Tired) and NAUSEA (Feeling queasy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product used was not provided by the reporter.  Treatment information was not provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: Follow-up information will be processed at the same time as the initial report. Follow-up updated outcome for events.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Vaccination site erythema
Clinical narrative: headache; Red at the injection site which is gradually going all the way upto the shoulder; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) and VACCINATION SITE ERYTHEMA (Red at the injection site which is gradually going all the way upto the shoulder) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced HEADACHE (headache) and VACCINATION SITE ERYTHEMA (Red at the injection site which is gradually going all the way upto the shoulder). The patient was treated with IBUPROFEN (ADVIL) ongoing since an unknown date at a dose of UNK dosage form. At the time of the report, HEADACHE (headache) and VACCINATION SITE ERYTHEMA (Red at the injection site which is gradually going all the way upto the shoulder) outcome was unknown. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant medication information not provided.   Most recent FOLLOW-UP information incorporated above includes: On 13-Mar-2021: NNI
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site swelling, Vaccination site warmth
Clinical narrative: A little pink; Vaccination site swelling; Vaccination site warmth; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (A little pink), VACCINATION SITE SWELLING (Vaccination site swelling) and VACCINATION SITE WARMTH (Vaccination site warmth) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (A little pink), VACCINATION SITE SWELLING (Vaccination site swelling) and VACCINATION SITE WARMTH (Vaccination site warmth). The patient was treated with HYDROCORTISONE at an unspecified dose and frequency. At the time of the report, VACCINATION SITE ERYTHEMA (A little pink), VACCINATION SITE SWELLING (Vaccination site swelling) and VACCINATION SITE WARMTH (Vaccination site warmth) had resolved.      No relevant concomitant medications reported.  Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: initial additional
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Lethargy, Peripheral swelling
Clinical narrative: FEET SWELLING; lethargy; fever; soreness in shoulder near injection site,; chills; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (FEET SWELLING), LETHARGY (lethargy), PYREXIA (fever), ARTHRALGIA (soreness in shoulder near injection site,) and CHILLS (chills) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced PERIPHERAL SWELLING (FEET SWELLING), LETHARGY (lethargy), PYREXIA (fever), ARTHRALGIA (soreness in shoulder near injection site,), CHILLS (chills) and FATIGUE (fatigue). At the time of the report, PERIPHERAL SWELLING (FEET SWELLING), LETHARGY (lethargy), PYREXIA (fever), ARTHRALGIA (soreness in shoulder near injection site,), CHILLS (chills) and FATIGUE (fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Mar-2021, SARS-CoV-2 test: negative (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication information provided.  Treatment information not given.
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test
Clinical narrative: FEET SWELLING; lethargy; fever; soreness in shoulder near injection site,; chills; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (FEET SWELLING), LETHARGY (lethargy), PYREXIA (fever), ARTHRALGIA (soreness in shoulder near injection site,) and CHILLS (chills) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced PERIPHERAL SWELLING (FEET SWELLING), LETHARGY (lethargy), PYREXIA (fever), ARTHRALGIA (soreness in shoulder near injection site,), CHILLS (chills) and FATIGUE (fatigue). At the time of the report, PERIPHERAL SWELLING (FEET SWELLING), LETHARGY (lethargy), PYREXIA (fever), ARTHRALGIA (soreness in shoulder near injection site,), CHILLS (chills) and FATIGUE (fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Mar-2021, SARS-CoV-2 test: negative (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication information provided.  Treatment information not given.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Cold sweat, Dizziness, Nausea, Pain
Clinical narrative: Pain; Feel feverish; Nausea; Extreme dizziness; Cold sweats; Burning inflammation throughout their body; This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (Burning inflammation throughout their body), DIZZINESS (Extreme dizziness), COLD SWEAT (Cold sweats), PAIN (Pain) and PYREXIA (Feel feverish) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced BURNING SENSATION (Burning inflammation throughout their body). On 11-Mar-2021, the patient experienced DIZZINESS (Extreme dizziness), COLD SWEAT (Cold sweats), PYREXIA (Feel feverish) and NAUSEA (Nausea). On an unknown date, the patient experienced PAIN (Pain). On 11-Mar-2021, BURNING SENSATION (Burning inflammation throughout their body) and PAIN (Pain) had resolved. At the time of the report, DIZZINESS (Extreme dizziness), COLD SWEAT (Cold sweats), PYREXIA (Feel feverish) and NAUSEA (Nausea) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Pain; Feel feverish; Nausea; Extreme dizziness; Cold sweats; Burning inflammation throughout their body; This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (Burning inflammation throughout their body), DIZZINESS (Extreme dizziness), COLD SWEAT (Cold sweats), PAIN (Pain) and PYREXIA (Feel feverish) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced BURNING SENSATION (Burning inflammation throughout their body). On 11-Mar-2021, the patient experienced DIZZINESS (Extreme dizziness), COLD SWEAT (Cold sweats), PYREXIA (Feel feverish) and NAUSEA (Nausea). On an unknown date, the patient experienced PAIN (Pain). On 11-Mar-2021, BURNING SENSATION (Burning inflammation throughout their body) and PAIN (Pain) had resolved. At the time of the report, DIZZINESS (Extreme dizziness), COLD SWEAT (Cold sweats), PYREXIA (Feel feverish) and NAUSEA (Nausea) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Vaccination site erythema, Vaccination site pain, Vaccination site pruritus
Clinical narrative: Injection site is very itchy; Injection site is red; She felt unwell; Injection site soreness; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (She felt unwell), VACCINATION SITE PAIN (Injection site soreness), VACCINATION SITE PRURITUS (Injection site is very itchy) and VACCINATION SITE ERYTHEMA (Injection site is red) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced MALAISE (She felt unwell) and VACCINATION SITE PAIN (Injection site soreness). On 12-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (Injection site is very itchy) and VACCINATION SITE ERYTHEMA (Injection site is red). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, MALAISE (She felt unwell) and VACCINATION SITE PAIN (Injection site soreness) had resolved and VACCINATION SITE PRURITUS (Injection site is very itchy) and VACCINATION SITE ERYTHEMA (Injection site is red) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Arthritis
Clinical narrative: Whole body is inflamed with arthritis; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRITIS (Whole body is inflamed with arthritis) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ARTHRITIS (Whole body is inflamed with arthritis). At the time of the report, ARTHRITIS (Whole body is inflamed with arthritis) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided. Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Rash erythematous, Rash pruritic
Clinical narrative: itcy rash; red rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (itcy rash) and RASH ERYTHEMATOUS (red rash) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     No medical history information provided by the reporter.  Concomitant products included METOPROLOL, AMLODIPINE and ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced RASH PRURITIC (itcy rash) and RASH ERYTHEMATOUS (red rash). At the time of the report, RASH PRURITIC (itcy rash) and RASH ERYTHEMATOUS (red rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient reported that the rash is red and looks like a donut with circle in the middle. No treatment details reported.    Most recent FOLLOW-UP information incorporated above includes: On 12-Mar-2021: NNI
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Arm is really hurting; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm is really hurting) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 027A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm is really hurting). The patient was treated with PARACETAMOL (TYLENOL) for Pain in arm, at a dose of UNK dosage form. At the time of the report, PAIN IN EXTREMITY (Arm is really hurting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (Rash). At the time of the report, RASH (Rash) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported No treatment medication was reported
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Body temperature, Chest pain, Chills
Clinical narrative: a sore arm; general body aches; pain in his chest; pain in his back; chills; low grade fever 101; very tired; joint pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (a sore arm), MYALGIA (general body aches), CHEST PAIN (pain in his chest), BACK PAIN (pain in his back) and CHILLS (chills) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ALLOPURINOL for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced PAIN IN EXTREMITY (a sore arm), MYALGIA (general body aches), CHEST PAIN (pain in his chest), BACK PAIN (pain in his back), CHILLS (chills), PYREXIA (low grade fever 101), FATIGUE (very tired) and ARTHRALGIA (joint pain). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at a dose of UNK dosage form. At the time of the report, PAIN IN EXTREMITY (a sore arm), MYALGIA (general body aches), CHEST PAIN (pain in his chest), BACK PAIN (pain in his back), CHILLS (chills), PYREXIA (low grade fever 101), FATIGUE (very tired) and ARTHRALGIA (joint pain) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Mar-2021, Body temperature: 101 (High) 101F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications also included angiotensin-converting enzyme(ACE) inhibitors.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Myalgia, Pain in extremity, Pyrexia
Clinical narrative: a sore arm; general body aches; pain in his chest; pain in his back; chills; low grade fever 101; very tired; joint pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (a sore arm), MYALGIA (general body aches), CHEST PAIN (pain in his chest), BACK PAIN (pain in his back) and CHILLS (chills) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ALLOPURINOL for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced PAIN IN EXTREMITY (a sore arm), MYALGIA (general body aches), CHEST PAIN (pain in his chest), BACK PAIN (pain in his back), CHILLS (chills), PYREXIA (low grade fever 101), FATIGUE (very tired) and ARTHRALGIA (joint pain). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at a dose of UNK dosage form. At the time of the report, PAIN IN EXTREMITY (a sore arm), MYALGIA (general body aches), CHEST PAIN (pain in his chest), BACK PAIN (pain in his back), CHILLS (chills), PYREXIA (low grade fever 101), FATIGUE (very tired) and ARTHRALGIA (joint pain) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Mar-2021, Body temperature: 101 (High) 101F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications also included angiotensin-converting enzyme(ACE) inhibitors.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Arthritis, Fatigue, Lethargy, Myalgia
Clinical narrative: Delayed reaction; Arthritis is ten times worse; very lethargic; Became very tired; Had a low grade fever; Worsen muscle pain; Worsen joint pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (Delayed reaction), ARTHRITIS (Arthritis is ten times worse), LETHARGY (very lethargic), FATIGUE (Became very tired) and PYREXIA (Had a low grade fever) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for an unreported indication: shingles vaccine (Symptoms (associate with the COVID-19 vaccination) are similar to symptoms when patient received shingles vaccine several years ago ). Concurrent medical conditions included Arthritis. Concomitant products included CELECOXIB (CELEBREX), FOLIC ACID, MULTIVITAMIN [VITAMINS NOS], ATORVASTATIN, LOSARTAN POTASSIUM, LAMOTRIGINE (LAMICTAL) and QUETIAPINE for an unknown indication.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Feb-2021, the patient experienced VACCINATION SITE REACTION (Delayed reaction), ARTHRITIS (Arthritis is ten times worse), LETHARGY (very lethargic), FATIGUE (Became very tired), PYREXIA (Had a low grade fever), MYALGIA (Worsen muscle pain) and ARTHRALGIA (Worsen joint pain). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE REACTION (Delayed reaction), LETHARGY (very lethargic), FATIGUE (Became very tired) and PYREXIA (Had a low grade fever) outcome was unknown and ARTHRITIS (Arthritis is ten times worse), MYALGIA (Worsen muscle pain) and ARTHRALGIA (Worsen joint pain) had not resolved.            It was reported that after the second vaccine patient had arthritis,  ten times worse with her muscle and joint pain.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site reaction
Clinical narrative: Delayed reaction; Arthritis is ten times worse; very lethargic; Became very tired; Had a low grade fever; Worsen muscle pain; Worsen joint pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (Delayed reaction), ARTHRITIS (Arthritis is ten times worse), LETHARGY (very lethargic), FATIGUE (Became very tired) and PYREXIA (Had a low grade fever) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for an unreported indication: shingles vaccine (Symptoms (associate with the COVID-19 vaccination) are similar to symptoms when patient received shingles vaccine several years ago ). Concurrent medical conditions included Arthritis. Concomitant products included CELECOXIB (CELEBREX), FOLIC ACID, MULTIVITAMIN [VITAMINS NOS], ATORVASTATIN, LOSARTAN POTASSIUM, LAMOTRIGINE (LAMICTAL) and QUETIAPINE for an unknown indication.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Feb-2021, the patient experienced VACCINATION SITE REACTION (Delayed reaction), ARTHRITIS (Arthritis is ten times worse), LETHARGY (very lethargic), FATIGUE (Became very tired), PYREXIA (Had a low grade fever), MYALGIA (Worsen muscle pain) and ARTHRALGIA (Worsen joint pain). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE REACTION (Delayed reaction), LETHARGY (very lethargic), FATIGUE (Became very tired) and PYREXIA (Had a low grade fever) outcome was unknown and ARTHRITIS (Arthritis is ten times worse), MYALGIA (Worsen muscle pain) and ARTHRALGIA (Worsen joint pain) had not resolved.            It was reported that after the second vaccine patient had arthritis,  ten times worse with her muscle and joint pain.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Pruritus, Pyrexia, Skin mass
Clinical narrative: Itching; Big lump up there; Redness getting wider; When she touch it feels warm; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching), SKIN MASS (Big lump up there), ERYTHEMA (Redness getting wider), FEELING HOT (When she touch it feels warm) and PYREXIA (Fever) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 02C1Z1A) for COVID-19 vaccination.     No medical history information reported.  Concomitant products included HYDROCHLOROTHIAZIDE, TRIAMTERENE (TRIAMTERENE & HCTZ), AMLODIPINE, SIMVASTATIN, METFORMIN, BENAZEPRIL, LEVOTHYROXINE and OMEPRAZOLE for an unknown indication.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced PRURITUS (Itching), SKIN MASS (Big lump up there), ERYTHEMA (Redness getting wider), FEELING HOT (When she touch it feels warm) and PYREXIA (Fever). The patient was treated with LORATADINE at an unspecified dose and frequency. At the time of the report, PRURITUS (Itching), SKIN MASS (Big lump up there), ERYTHEMA (Redness getting wider), FEELING HOT (When she touch it feels warm) and PYREXIA (Fever) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-105036 (Patient Link).
Age: 96.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Rash
Clinical narrative: Diagnosed with shingle; Rash on the Left eye; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HERPES ZOSTER (Diagnosed with shingle) and RASH (Rash on the Left eye) in a 96-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included RIVAROXABAN (XARELTO), LEVOTHYROXINE, HYDROBROMIDE DEXTROMETHORPHAN, ATENOLOL, NIFEDIPINE (SELCA), PREGABALIN (LYRICA), SOTALOL, POTASSIUM CHLORIDE, LATANOPROST and ALENDRONATE SODIUM (ALENDRONATO) for an unknown indication.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, the patient experienced HERPES ZOSTER (Diagnosed with shingle) and RASH (Rash on the Left eye). The patient was treated with VALACICLOVIR HYDROCHLORIDE (VALTREX) for Antiviral treatment, at a dose of 100 milligram. At the time of the report, HERPES ZOSTER (Diagnosed with shingle) outcome was unknown and RASH (Rash on the Left eye) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Insomnia, Nausea, Pain, Pyrexia
Clinical narrative: trouble sleeping 2 day; achy; fever; chills; nausea; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (trouble sleeping 2 day), PAIN (achy), PYREXIA (fever), CHILLS (chills) and NAUSEA (nausea) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Urinary incontinence. Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced INSOMNIA (trouble sleeping 2 day), PAIN (achy), PYREXIA (fever), CHILLS (chills) and NAUSEA (nausea). At the time of the report, INSOMNIA (trouble sleeping 2 day), PAIN (achy), PYREXIA (fever), CHILLS (chills) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant products include unspecified medicine for urinary incontinence.  Treatment medications was not provided by the reporter
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Hypertension, Palpitations
Clinical narrative: Palpitations; Blood pressure high; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (Palpitations) and HYPERTENSION (Blood pressure high) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L02A and 026L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Feb-2021, the patient experienced PALPITATIONS (Palpitations) and HYPERTENSION (Blood pressure high). At the time of the report, PALPITATIONS (Palpitations) and HYPERTENSION (Blood pressure high) had not resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Feb-2021, Blood pressure measurement: 150/70 mmHg (High) 3 weeks after second dose vaccination it's constant.. On an unknown date, Blood pressure measurement: 110/70 mmHg (normal) Baseline before receiving vaccine..         No concomitant medication was reported  No treatment medication was reported